|
|
||||||||
Institut fuer Pharmakologie, Universitaet zu Koeln, 50931 Koeln, Germany
| |
ABSTRACT |
|---|
|
|
|---|
There are different methods to measure the unstable molecule nitric oxide (NO). We will describe a new sensitive method to measure NO by reconversion of nitrate/nitrite to NO, which will be determined with an amperometric Clark-type electrode. Nitrate and nitrite are the degradation products of NO. First, nitrate is enzymatically converted to nitrite with the use of the nitrate reductase. Second, nitrite is reduced to equimolar NO concentrations by an acidic iodide solution. The detection limit of the electrode in an aqueous solution was 2 nmol/l NO (meaning the threshold was depending on the volume added: 500 µl of a 0.2 µmol/l nitrite solution added to a 10-ml bath). This method provides the ability to assess basal and agonist-stimulated NO releases of different biological models. We measured basal and carbachol-stimulated NO release of native endothelial cells from porcine coronary arteries and porcine aortic endothelial cell cultures. Moreover, it was possible to measure the nitrate/nitrite concentration in the coronary effluent of a guinea pig heart. In conclusion, we present a valid, highly sensitive new method of measuring nitrite/NO in biological systems with a commercially available electrode.
nitric oxide; endothelium; nitrite
| |
INTRODUCTION |
|---|
|
|
|---|
NITRIC OXIDE (NO) is a small, diffusible molecule with a short half-life (8) with various biological functions (4, 12, 14). It was first discovered by Furchgott (5) to be an endothelium-derived relaxing factor, which was identified as being identical to NO by Palmer et al. (15) and Ignarro et al. (9) in 1987. Up until now, three different isoforms of NO synthases (NOS) have been identified (4, 14). The neuronal NOS, which is calcium/calmodulin dependent, produces NO that acts as a neurotransmitter. After stimulation, macrophages express large amounts of a calcium/calmodulin-independent NOS-releasing NO in high concentrations for bactericidal purposes. The constitutive endothelial NOS causes vascular relaxation via cGMP-mediated mechanisms, and, moreover, albuminally released NO inhibits platelet aggregation and leukocyte adhesion (14). Because NO has a short half-life (2-30 s) (8), it is difficult to measure authentic NO. It rapidly decomposes to nitrate and nitrite, which may accumulate in the sample. There are different methods of determining NO, which have been described in detail elsewhere (1). Briefly, it is possible to measure NO by using a bioassay (6), an oxyhemoglobin assay (10), electron paramagnetic resonance (7), chemiluminescence (15), HPLC (11), the Griess reaction (17), or different electrochemical electrodes (3, 13, 19). Moreover, it is possible to measure NO indirectly via its second messenger, cGMP.
Up until now, the Griess reaction has been used to measure nitrite/nitrate, although the detection limit of this technique is in a micromolar range, which is usually only reached by induction of the inducible NOS.
This study presents a new, sensitive method to determine nitrite/NO with a commercially available electrochemical NO electrode (WPI, Sarasota, FL). We will describe that it is possible to measure NO in aqueous solutions from different biological models by a conversion of nitrite to NO. A big advantage of this method is that the total (basal and agonist-induced) NO release of cells in culture can be measured because the stable degradation products of NO (nitrate/nitrite) accumulate in the incubation buffer.
| |
METHODS |
|---|
|
|
|---|
Calibration of the NO electrode.
The amperometric ISO-NO electrode (WPI) measures NO by oxidizing it at
the working electrode. The resulting current is displayed in
picoamperes and is proportional to NO concentrations (Fig. 1). To prevent nitrate and nitrite from
interfering with the electrode, it is coated with a specialized
membrane (WPI); other diffusable gases such as CO are not measured
because of the potential at the electrode. The electrode was calibrated
by using a modification of the protocol (3, 19) given by
the manufacturer. A chemical titration calibration was performed by
using an acidic iodide solution (0.1 mol/l
H2SO4, 0.14 mol/l
K2SO4, 0.1 mol/l KI), to which equal volumes of
different KNO2 solutions were added (Figs. 2 and 3).
NO is formed stoichiometrically and is measured directly. Briefly, 500 µl of KNO2 were added to 10 ml of the acidic solution at
room temperature while being stirred (100 rpm). The same calibration was performed with increasing volumes of a KNO2 solution of
a definite concentration (5 µmol/l). Instantly the nitrite is reduced to NO, which is constantly measured by the electrode that is placed in
the solution. The detection limit of the electrode is 2 nmol/l NO
(2, 3) in an aqueous solution, which means that a minimum of 50 µl of a solution that contains 2 µmol/l nitrite has to be added to the 10-ml bath to be detectable. Therefore, in an
experiment, the added nitrite sample is diluted according to its volume
in the 10-ml bath, resulting in a much lower concentration. It is important for the volume of the sample containing nitrite to be greater
than the detection limit in the 10-ml bath. It is possible to
add solutions up to a volume of 500 µl (single addition) to the 10-ml
solution without disturbing the measurement. When performing an
experiment, we did not add more than 1 ml (total sum of serial injections) into the 10-ml bath; afterward we replaced the bath with a
fresh solution to perform further experiments. We always took the peak
currents to quantify our values.
|
|
|
Preparation of porcine coronary arteries. Coronary arteries of female pigs were prepared immediately after excision of the hearts and stored in oxygenated Tyrode solution. Special care was taken to preserve the endothelium during removal of fat and connective tissue. The artery was cut into rings of 0.8 cm (30-50 mg wet wt, 2-mm diameter), opened longitudinally, fixed on customized needles, and placed in an organ bath.
Cell culture of porcine aortic endothelial cells.
Porcine aortic endothelial cells (PAEC) were harvested and cultured as
described elsewhere (3). Briefly, porcine aorta were
obtained fresh from a local abattoir, and the endothelial cells were
isolated enzymatically and cultured in medium 199 with 10% fetal calf
serum. On confluence (2-3 days), the cells were detached by
treatment with trypsin, seeded onto sterile glass coverslips, and grown
to subconfluence (
70-80%). Only cells from passage
2 were used for the experiments. The purity of the PAEC culture
was tested with different immunochemical markers.
Preparation of guinea pig hearts according to Langendorff. Hearts of adult guinea pigs were prepared as previously described (16). Briefly, the guinea pigs were heparinized (1,000 IU heparin/kg), and the hearts were excised. They were perfused at a constant perfusion pressure of 60 mmHg with an oxygenated Tyrode solution at 37°C. The hearts were beating spontaneously, and the left ventricular pressure was recorded isovolumetrically.
Measurement of the nitrite/NO production. The vessel pieces (30-50 mg wet wt) were fixed on a plastic rod with the endothelium outside (3-mm diameter) and incubated for 30 min in 500 µl of HEPES buffer (in mmol/l: 5 HEPES, 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, and 10 glucose, adjusted to a pH of 7.4) at 25°C (without stirring). The incubate was then treated with 50 µl of a NADPH-FAD mixture (1.5:0.03 mg/ml) and 1 min later with 15 µl of nitrate reductase solution (10 U/ml; Roche; final concentrations of 0.3 U/ml nitrate reductase). The resulting mixture was incubated at room temperature for another 30 min. The nitrite/NO concentration was estimated as described under Calibration of the NO electrode.
Endothelial cell cultures were washed two times with HEPES buffer and incubated for 120 min at 37°C. Defined volumes (500 µl) of the supernatant (1.5 ml of HEPES buffer) of PAEC cell cultures (10-cm dishes) were taken and treated the same way as described above. The coronary effluent of the guinea pig hearts was sampled for nitrite/NO analysis as described above. If the nitrite concentration of the samples, especially from the native coronary vessels, was out of our calibration curve (too high), we reduced the added volume accordingly.| |
RESULTS |
|---|
|
|
|---|
Calibration. A calibration with a KNO2 solution (500 µl) in increasing concentrations showed a concentration-dependent linear increase in NO with a detection limit of 2 nmol/l in the 10-ml bath (Figs. 2 and 3). Increasing volumes of a fixed concentration of KNO2 resulted in a linear signal too (2). A sharp increase in NO was detected after application of the KNO2 solution, which slowly decreased down to basal levels, depending on the height of the signal (Fig. 2). The baseline stability did not change when several reductants were injected (up to 8 times). The detection limit using our method was 0.2 µmol/l nitrite in 500 µl and, therefore, was lower than the detection limit of a colorimetric assay, as well as a chemiluminescent Griess assay (detection limits according to the manufacturers, Roche and R&D) (Fig. 3).
Additionally, we could show in our system that the spontaneous NO donor S-nitroso-N-acetyl-penicillamine (freshly prepared) released NO in a dose-dependent manner (data not shown). The buffer (HEPES-buffered saline solution) did not show any NO signals. Addition of cysteine up to a concentration of 1 mmol/l did not alter the recovery of nitrite. The same refers to solutions of protein (BSA; up to 1 mg/ml). There was no significant difference between the calibration curves of solutions with or without proteins and CysSH (data not shown).Measurement of NO from native vessels.
Isolated porcine coronary arteries released nitrate/NO in a
time-dependent manner (Fig. 4)
(n = 4). We standardized our experiments to a 30-min
incubation of the vessels. Basal nitrite/NO levels (per ring) released
by the constitutive NOS after 30 min of incubation were
350 ± 17 pmol · 10 mg
1 · 30 min
1 (n = 25) (Fig.
5). Additionally, we induced an enhanced
NO release of the vessels by using carbachol as a conventional agonist.
After a period of 30 min, carbachol (1 µmol/l) significantly elevated nitrite/NO levels (+50 ± 9%; n = 6; Fig. 5). The
basal and the carbachol-induced NO formation could be blocked by the
NOS inhibitor NG-nitro-L-arginine
methyl ester (0.1 mmol/l), which shows the specificity of our
measurements (data not shown).
|
|
Measurement of NO from endothelial cell cultures.
Cultured endothelial monolayers showed a basal NO release of 186 ± 17 pmol · 10 cm
2 · 30 min
1. We used shear stress to induce an increased NO
formation, which resulted in stimulation of the NO release (658 ± 23 pmol · 10 cm
2 · 30 min
1;
n = 3). To compare our method with conventional Griess
assays, we performed measurements with a colorimetric assay (Roche) and a chemiluminescent assay (R&D). We were not able to detect nitrite in
the supernatant of endothelial cell cultures with these methods; thus
it seemed that the sensitivity in these systems was too low.
Measurement of NO in heart perfusate. The effluent of a Langendorff-perused guinea pig heart was analyzed to measure nitrite/NO. The electrode was sensitive enough to monitor basal NO release after 30 min of equilibration in the effluent. The basal NO concentration was 700 pmol/min at a flow of 11 ml/min.
| |
DISCUSSION |
|---|
|
|
|---|
We could show that it is possible to measure basal and agonist-induced NO release of endothelial cells with an electrochemical electrode by converting nitrite back to NO. This method is very sensitive, with a detection limit of 2 nmol/l, which means that, in our system, a sample (500 µl) with a nitrite content of 0.2 µmol/l would be detected. It even provides the ability to measure NO in heart perfusate. The method is based on the conversion of nitrite to NO in acidic iodide solutions, which can be detected by the electrode. Nitrite is one of the two biological degradation products of NO. The other product is nitrate. The enzymatic conversion of nitrate to nitrite is necessary to measure the total amount of NO formed by the cells because the iodide solution is not strong enough to reduce nitrate to NO. Without a conversion, significantly lower levels of NO are detected (data not shown).
Because the endothelial cells are incubated for a fixed time period, we cannot monitor the actual NO release online at a defined time, which is possible with the electrode (3, 19). On the other hand, it is a big advantage to be able to measure basal NO release, which is hardly possible if the electrode is placed above the endothelial cells and NO is measured directly, because in this case the basal NO liberation is incorporated into the baseline and only a stimulated NO release can be detected. Additionally, the total NO amount formed would be obtained, even if the NO is inactivated by oxygen radicals, because, at the end, nitrite will be generated. Compared with the Griess reaction, the typical assay used to measure nitrite and nitrate, our detection limit is significantly lower (Fig. 3) (18). Moreover, the Griess reaction might interfere with thiols, proteins, and plasma constituents, whereas our methods seems not to be affected up to very high unphysiological concentrations (18). The chemiluminescent NO assay offers a detection limit of the same range but is significantly more expensive. Additionally, because nitrate and nitrite are stable compounds, one does not need to worry about the short half-life of NO, and it is possible to freeze biological samples and measure them later. Additionally, the volume that is needed to perform a measurement is low (50-500 µl), and the time to perform a measurement is short. To work with this highly sensitive electrode, it is necessary to ground the experimenter and the recording devices thoroughly, otherwise small changes in electric currents will interfere with the recording. The same refers to changes in pH, flow, and temperature.
In summary, we are presenting a highly sensitive method to measure NO in biological samples by conversion of nitrite with a commercial NO electrode.
| |
ACKNOWLEDGEMENTS |
|---|
Part of this study was supported by a grant from the Köln-Fortune program of the medical faculty of the University of Cologne (Cologne, Germany).
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: R. Berkels, Institut fuer Pharmakologie, Gleueler Str. 24, 50931 Koeln, Germany (E-mail: Reinhard.Berkels{at}medizin.uni-koeln.de).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 22 December 1999; accepted in final form 11 August 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Archer, S.
Measurement of nitric oxide in biological models.
FASEB J
7:
349-360,
1993[Abstract].
2.
Berkels, R,
Bertsch A,
Breitenbach T,
Klaus W,
and
Roesen R.
The calcium antagonist nifedipine stimulates endothelial NO release in therapeutical concentrations.
Pharm Pharmacol Lett
6:
75-78,
1996.
3.
Berkels, R,
Mueller A,
Roesen R,
and
Klaus W.
Nifedipine and Bay K 8644 induce an increase of [Ca2+]i and NO in endothelial cells.
J Cardiovasc Pharmacol Ther
4:
175-181,
1999.
4.
Forstermann, U,
Closs EI,
Pollock JS,
Nakane M,
Schwarz P,
Gath I,
and
Kleinert H.
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.
Hypertension
23:
1121-1131,
1994
5.
Furchgott, RF,
and
Zawadzki JV.
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.
Nature
288:
373-376,
1980[Medline].
6.
Gryglewski, RJ,
Moncada S,
and
Palmer RM.
Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.
Br J Pharmacol
87:
685-694,
1986[Web of Science][Medline].
7.
Henry, Y,
Ducrocq C,
Drapier JC,
Servent D,
Pellat C,
and
Guissani A.
Nitric oxide, a biological effector. Electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells.
Eur Biophys J
20:
1-15,
1991[Web of Science][Medline].
8.
Ignarro, LJ.
Endothelium-derived nitric oxide: actions and properties.
FASEB J
3:
31-36,
1989[Abstract].
9.
Ignarro, LJ,
Buga GM,
Wood KS,
Byrns RE,
and
Chaudhuri G.
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Proc Natl Acad Sci USA
84:
9265-9269,
1987
10.
Kelm, M,
Feelisch M,
Spahr R,
Piper HM,
Noack E,
and
Schrader J.
Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells.
Biochem Biophys Res Commun
154:
236-244,
1988[Web of Science][Medline].
11.
Kelm, M,
Preik-Steinhoff H,
Preik M,
and
Strauer BE.
Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway.
Cardiovasc Res
41:
765-772,
1999
12.
Lane, P,
and
Gross SS.
Cell signaling by nitric oxide.
Semin Nephrol
19:
215-229,
1999[Web of Science][Medline].
13.
Malinski, T,
Mesaros S,
Patton SR,
and
Mesarosova A.
Direct measurement of nitric oxide in the cardiovascular system.
Physiol Res
45:
279-284,
1996[Web of Science][Medline].
14.
Moncada, S,
Palmer RM,
and
Higgs EA.
Nitric oxide: physiology, pathophysiology, and pharmacology.
Pharmacol Rev
43:
109-142,
1991[Web of Science][Medline].
15.
Palmer, RM,
Ferrige AG,
and
Moncada S.
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
Nature
327:
524-526,
1987[Medline].
16.
Rosen, R,
Marsen A,
and
Klaus W.
Local myocardial perfusion and epicardial NADH-fluorescence after coronary artery ligation in the isolated guinea pig heart.
Basic Res Cardiol
79:
59-67,
1984[Web of Science][Medline].
17.
Thomsen, LL,
Ching LM,
and
Baguley BC.
Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid.
Cancer Res
50:
6966-6970,
1990
18.
Tsikas, D,
Gutzki FM,
Rossa S,
Bauer H,
Neumann C,
Dockendorff K,
Sandmann J,
and
Frolich JC.
Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: problems with the Griess assay-solutions by gas chromatography-mass spectrometry.
Anal Biochem
244:
208-220,
1997[Web of Science][Medline].
19.
Tsukahara, H,
Gordienko DV,
and
Goligorsky MS.
Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells.
Biochem Biophys Res Commun
193:
722-729,
1993[Web of Science][Medline].
This article has been cited by other articles:
![]() |
H. Zhang, J. Zhang, Z. Ungvari, and C. Zhang Resveratrol Improves Endothelial Function: Role of TNF{alpha} and Vascular Oxidative Stress Arterioscler Thromb Vasc Biol, August 1, 2009; 29(8): 1164 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Monsalve, P. J. Oviedo, M. A. Garcia-Perez, J. J. Tarin, A. Cano, and C. Hermenegildo Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells Cardiovasc Res, January 1, 2007; 73(1): 66 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J Ray and J. M Marshall Measurement of nitric oxide release evoked by systemic hypoxia and adenosine from rat skeletal muscle in vivo J. Physiol., November 1, 2005; 568(3): 967 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Masri, S. A. A. Comhair, T. Koeck, W. Xu, A. Janocha, S. Ghosh, R. A. Dweik, J. Golish, M. Kinter, D. J. Stuehr, et al. Abnormalities in Nitric Oxide and Its Derivatives in Lung Cancer Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 597 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Adams, J. Bassuk, D. Wu, M. Grana, P. Kurlansky, and M. A. Sackner Periodic acceleration: effects on vasoactive, fibrinolytic, and coagulation factors J Appl Physiol, March 1, 2005; 98(3): 1083 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Zhao, P. E. Pergola, L. J. Roman, and D. L. Kellogg Jr. Bioactive nitric oxide concentration does not increase during reactive hyperemia in human skin J Appl Physiol, February 1, 2004; 96(2): 628 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Bethke, M. R. Badger, and R. L. Jones Apoplastic Synthesis of Nitric Oxide by Plant Tissues PLANT CELL, February 1, 2004; 16(2): 332 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Kellogg Jr., J. L. Zhao, C. Friel, and L. J. Roman Nitric oxide concentration increases in the cutaneous interstitial space during heat stress in humans J Appl Physiol, May 1, 2003; 94(5): 1971 - 1977. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |